Healthcare and Life Sciences

Weil is a market leader in advising on cutting-edge global healthcare and life science matters and transactions.

Weil has experience advising on issues across all stages of the product life cycle, from the lab bench to the pharmacy shelf. Our team has deep experience across transactions and disputes concerning small molecule, biologic, drug device and gene therapy assets, as well as emerging platform assets in the drug design, drug discovery and target discovery space. Weil regularly advises private equity funds and venture capital firms on their investment in the global healthcare and life sciences industry, as well as guiding healthcare and life sciences companies on their most complex and high-profile M&A transactions. 

Our team integrates industry-leading lawyers across Corporate, Private Equity, M&A, Litigation and Restructuring practices to advise a “who’s who” list of clients who invest and/or operate in the healthcare and life science industry. Our “One Firm” approach combines knowledge of science, business, deal, finance and capital markets, industry insights and law to deliver superior results and ensures seamless, global coordination and efficiency. Clients view us not only as legal advisors, but as strategic business partners who understand the unique challenges and opportunities of their business needs.

In a rapidly evolving global landscape, we are uniquely equipped to guide global healthcare and life sciences clients and investors  through complex, emerging issues and transactions, such as how to navigate the integration of artificial intelligence into drug and target discovery pathways and how its effects are transforming the industry—unlocking new opportunities while raising critical considerations around ownership, licensing, data integrity, compliance, and risk management. Our team stands at the forefront, delivering sophisticated counsel at the cutting edge of scientific innovation and transactional sophistication.

Our key areas of expertise include

Mergers & Acquisitions and Private Equity

Collaborations, Alliances and Licensing

Capital Markets

Antitrust

Litigation

Restructuring

Key Contacts

Yehudah Buchweitz

Yehudah L. Buchweitz

Partner

New York


Gareth Clark

Gareth Clark

Partner

New York


Mariel E. Cruz

Mariel E. Cruz

Partner

New York


Mei Dan

Mei Dan

Partner

Silicon Valley


Matthew J. Gilroy

Matthew J. Gilroy

Partner

New York


Merritt Johnson

Merritt S. Johnson

Partner

New York


Eoghan P. Keenan

Eoghan Patrick Keenan

Partner

New York


David J. Lender

David J. Lender

Partner

New York


Jessica Liou

Jessica Liou

Partner

New York


Alexander Lynch

Alex Lynch

Partner

New York


Michael Messina

Michael D. Messina

Partner

Boston


John O;Loughlin

John O'Loughlin

Partner

Washington, D.C.


Charan J. Sandhu

Charan J. Sandhu

Partner

New York


Kane Wishart

Kane Wishart

Partner

New York

See list of lawyers globally

Shortcut Links

A full-service player on the national stage, Weil Gotshal & Manges has a long history of dominance in servicing some of the most prominent brand names in the life sciences industry, and an extensive network of practitioners distributed among its many US offices through which to service them.”

LMG Life Sciences Guide

Named a “Leading” Firm for Life Sciences Nationally

Chambers USA 2024

Named a “Leading” Firm for Healthcare: Life Sciences

Legal 500 US 2024

Named a “Leading” Firm for Antitrust, Patent Litigation, Product Liability, and M&A

LMG Life Sciences 2024

Named Life Sciences “Practice Group of the Year”

Law360

Firm News & Announcements

View all